Thermo Fisher Scientific
 |
This article needs additional citations for verification. (August 2009) |
 |
|
| Type | Public (NYSE: TMO) S&P 500 Component |
|---|---|
| Industry | Laboratory equipment |
| Founded | 2006 by Merger of Thermo Electron and Fisher Scientific |
| Headquarters | Waltham, Massachusetts, USA |
| Key people | Marc N. Casper, President and CEO; Peter M. Wilver, CFO |
| Products | Analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics |
| Revenue |  $10.1 Billion USD (2009) |
| Net income | $850.3 Million USD (2009) |
| Employees | 39,000 (2011) |
| Website | www.thermofisher.com |
Thermo Fisher Scientific is an American precision laboratory equipment company that was created in 2006 by the merger of Thermo Electron and Fisher Scientific.
Predecessors and merger [edit]
Thermo Electron was founded in 1956 by George Hatsopoulos, an MIT PhD in mechanical engineering.[1] It focused on providing analytical and laboratory products and services, and had revenues of over $2 billion in 2004.[2]
Fisher Scientific was founded in 1902 by Chester G. Fisher. It focused on providing laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety, and education.[3]
On May 14, 2006, Thermo Electron and Fisher Scientific announced that they would merge in a tax-free, stock-for-stock exchange; the merged company was named Thermo Fisher Scientific.[4] On November 9, 2006, the companies announced that the merger had been completed.[4] However, the Federal Trade Commission ruled that this acquisition was anticompetitive with regard to centrifugal evaporators, requiring Fisher to divest Genevac.[5] In April 2007, Genevac was sold to Riverlake Partners LLC[6] and the merger closed with FTC approval.[7]
Currently, the company's products are sold under the brand names of Thermo Scientific, Fisher Scientific, and several other recognized brand names (e.g.Chromacol, Nalgene, Cellomics, Cole-Parmer, Pierce Protein Research and Fermentas). According to company figures, 46% of its sales are in life sciences, 20% in healthcare, and 34% in industrial/environmental and safety.[3]
Thermo Fisher has offices and operations in many countries, notably the U.S. and in Europe.
In May 2011, Thermo Fisher Scientific Inc. bought Phadia to expand in testing for allergies and autoimmune diseases for €2.47 billion ($3.5 billion) in cash purchase.[8]
In April 2013, Thermo Fisher announced it would be buying Life Technologies Corp for $13.6 billion in a deal that would rank the firm as one of the top two companies in the genetic testing field.[9]
References [edit]
- ^ http://web.mit.edu/newsoffice/founders/Thermo.html Company founding
- ^ Financial Statements for Thermo Fisher Scientific Inc. - Google Finance
- ^ a b Thermo Fisher Scientific : Corporate Profile
- ^ a b Merger of Thermo Electron and Fisher Scientific Completed, Forming Thermo Fisher Scientific, press release, November 9, 2006
- ^ Merger of Thermo and Fisher anticompetitive, FTC Ruling
- ^ 3 April 2007. Riverlake Partners, LLC Acquires UK-based Genevac, Ltd. Press Release.
- ^ FTC consent to Genevac divestiture, FTC news release
- ^ Thermo Fisher Rises to Record After $3.5 Billion Phadia Buy - Bloomberg
- ^ Bill Berkrot and Susan Kelly (15 April 2013). "Thermo Fisher to buy Life Tech for $13.6 billion". Reuters.
External links [edit]
- Thermo Scientific - part of Thermo Fisher Scientific
- Fisher Scientific - part of Thermo Fisher Scientific
- Fisher HealthCare Clinical Catalog - The Digital Edition
- Fisher HealthCare Rapid Diagnostics Catalog - The Digital Edition
- Thermo Scientific Pierce Antibodies - Antibody Division of Thermo Fisher Scientific
